TYCC
CELG

Texas Yale Capital Corp’s Celgene Corp CELG Stock Holding History

Texas Yale Capital Corp’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,246
Closed -$328K – 460
2017
Q3 		$328K Hold
2,246
– – 0.03% 376
2017
Q2 		$292K Hold
2,246
– – 0.03% 390
2017
Q1 		$279K Sell
2,246
-900
-29% -$108K 0.02% 391
2016
Q4 		$364K Hold
3,146
– – 0.03% 341
2016
Q3 		$329K Hold
3,146
– – 0.03% 370
2016
Q2 		$310K Sell
3,146
-900
-22% -$93.1K 0.03% 373
2016
Q1 		$405K Hold
4,046
– – 0.04% 327
2015
Q4 		$485K Hold
4,046
– – 0.05% 301
2015
Q3 		$438K Hold
4,046
– – 0.04% 326
2015
Q2 		$468K Buy
+4,046
New +$463K 0.04% 350

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Texas Yale Capital Corp's CELG Position: Q4 2017 in Review

Texas Yale Capital Corp sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 2,246 shares — an estimated $328K sold.

Texas Yale Capital Corp first reported a position in CELG in Q2 2015 and held it in 10 quarters. The position peaked at $485K in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Texas Yale Capital Corp reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Texas Yale Capital Corp sold 2,246 Celgene Corp shares in Q4 2017, an estimated $328K.
  • Texas Yale Capital Corp first reported a position in Celgene Corp in Q2 2015 and held it in 10 quarters.
  • Texas Yale Capital Corp's Celgene Corp position peaked at $485K in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Texas Yale Capital Corp's 13F filing for Q4 2017, filed 7 Feb 2018.